Discovery of Cyclic Peptidomimetic Ligands Targeting the Extracellular Domain of EGFR

被引：10

作者：

Zheng, Mengmeng ^{[1
]}

Li, Chunpu ^{[1
,2
,3
]}

Zhou, Mi ^{[1
]}

Jia, Ru ^{[2
,3
]}

Cai, Gang ^{[2
,3
]}

She, Fengyu ^{[1
]}

Wei, Lulu ^{[1
]}

Wang, Shaohui ^{[4
]}

Yu, Jie ^{[5
]}

Wang, Dingyan ^{[5
]}

Calcul, Laurent ^{[1
]}

Sun, Xingmin ^{[4
]}

Luo, Xiaomin ^{[5
]}

Cheng, Feng ^{[6
]}

Li, Qi ^{[2
,3
,7
]}

Wang, Yan ^{[2
,3
,7
]}

Cai, Jianfeng ^{[1
]}

机构：

[1] Univ S Florida, Dept Chem, Tampa, FL 33620 USA

[2] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, Shanghai 201203, Peoples R China

[3] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Canc Inst Med, Shanghai 201203, Peoples R China

[4] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA

[5] Chinese Acad Sci, Drug Discovery & Design Ctr, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China

[6] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33612 USA

[7] Shanghai Univ Tradit Chinese Med, Acad Integrat Med, Shanghai 201203, Peoples R China

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2021年 / 64卷 / 15期

基金：

中国国家自然科学基金;

关键词：

EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; GAMMA-AAPEPTIDES; PEPTIDE LIGAND; CANCER; BINDING; MUTATIONS; GEFITINIB; THERAPY;

D O I：

10.1021/acs.jmedchem.1c00607

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

It is very promising to target the extracellular domain of epidermal growth factor receptor (EGFR) for developing novel and selective anticancer therapies. Herein, we report the discovery of a novel small molecule, M-2-5, from a one-bead-two-compound (OBTC) cyclic gamma-AApeptide library. The molecule was found to bind tightly to the extracellular domain of EGFR. Intriguingly, this molecule could also effectively antagonize EGF-stimulated EGFR phosphorylation and downstream signal transduction. Furthermore, together with its remarkable resistance to proteolytic degradation, M-2-5 was shown to effectively inhibit cell proliferation and migration in vitro and suppresses the growth of tumor in the A549 xenograft model in vivo, highlighting its potential therapeutic application for cancer treatment.

引用

页码：11219 / 11228

页数：10

共 50 条

[31] Novel Cyclic Peptides for Targeting EGFR and EGRvIII Mutation for Drug Delivery
Furman, Olga
Zaporozhets, Alisa
Tobi, Dror
Bazylevich, Andrii
Firer, Michael A.
Patsenker, Leonid
Gellerman, Gary
Lubin, Bat Chen R.
[J]. PHARMACEUTICS, 2022, 14 (07)
[32] Targeting HER2-receptors with 177Lu-labeled triazole stapled cyclic peptidomimetic
Sharma, Amit Kumar
Satpati, Drishty
Sharma, Rohit
Das, Amit
Sarma, Haladhar Dev
Mukherjee, Archana
[J]. BIOORGANIC CHEMISTRY, 2023, 135
[33] A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
Keller, James
Nimnual, Anjaruwee S.
Varghese, Mathew S.
VanHeyst, Kristen A.
Hayman, Michael J.
Chan, Edward L.
[J]. MOLECULAR CANCER RESEARCH, 2016, 14 (08) : 740 - 752
[34] Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR
Zhou, Yaqiong
Zhang, Juan
Jin, Haizhen
Chen, Zhiguo
Wu, Qinhang
Li, Weiguang
Yue, Ming
Luo, Chen
Wang, Min
[J]. BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (08) : 737 - 743
[35] Discovery of peptide ligands targeting a specific ubiquitin-like domain-binding site in the deubiquitinase USP11
Spiliotopoulos, Anastasios
Ferreras, Lia Blokpoel
Densham, Ruth M.
Caulton, Simon G.
Maddison, Ben C.
Morris, Joanna R.
Dixon, James E.
Gough, Kevin C.
Dreveny, Ingrid
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (02) : 424 - 436
[36] Thermodynamic profiling of conformationally constrained cyclic ligands for the PDZ domain
Li, T
Saro, D
Spaller, MR
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (06) : 1385 - 1388
[37] Targeting specific interactions to improve binding properties of EGFR-kinase ligands
Jean-Claude, Bertrand
Williams, Chris
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
[38] Targeting specific interactions to improve binding properties of EGFR-kinase ligands
Ajamian, Alain
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[39] Targeting specific interactions to improve binding properties of EGFR-kinase ligands
Williams, Chris
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[40] Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells
Hanieh Hossein-Nejad-Ariani
Emad Althagafi
Kamaljit Kaur
[J]. Scientific Reports, 9

← 1 2 3 4 5 →